TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16291444

Group type: COMPARATOR
Intervention: No manipulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mechanical hemolysis via a 27-gauge needle
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Addition of potassium acetate (KAc)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Addition of KAc and mechanical hemolysis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correction factor for K+
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Using the correction factor with 500 mg/dL of p‐Hgb
Number of subjects: 20
Study: 12077012

Group type: COMPARATOR
Intervention: Post-exercise (31)P‐MRS indices of muscle oxidative metabolism in DM and PM patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Phosphocreatine and adenosine diphosphate recovery half-times in DM and PM patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maximum rate of mitochondrial ATP production in DM and PM patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Rate of proton efflux from muscle fibres in DM patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Rate of proton efflux from muscle fibres in PM patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: MRS-detectable abnormalities in DM and PM patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Correlation between MRS-detectable abnormalities and degree of inflammation or fatty infiltration of the muscle
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: In vivo findings in DM and PM patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Abnormal mitochondria seen in muscle biopsies of DM and PM patients
Number of subjects: 9
Study: 10780258

Group type: EXPERIMENTAL
Intervention: Dexamethasone (2 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cocaine (12 mg and 50 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Dexamethasone (0 mg)
Number of subjects: 8
Study: 7828296

Group type: EXPERIMENTAL
Intervention: Nutritional-hygienic (NH) intervention plus chlorthalidone
Number of subjects: 844

Group type: EXPERIMENTAL
Intervention: Nutritional-hygienic (NH) intervention plus acebutolol
Number of subjects: 844

Group type: COMPARATOR
Intervention: Nutritional-hygienic (NH) intervention only
Number of subjects: 844

Group type: EXPERIMENTAL
Intervention: Nutritional-hygienic (NH) intervention plus doxazosin mesylate
Number of subjects: 844

Group type: EXPERIMENTAL
Intervention: Nutritional-hygienic (NH) intervention plus amlodipine maleate
Number of subjects: 844

Group type: EXPERIMENTAL
Intervention: Nutritional-hygienic (NH) intervention plus enalapril maleate
Number of subjects: 844
Study: 2240382

Group type: EXPERIMENTAL
Intervention: Fish oil (1.8 g eicosapentaenoic acid and 1.2 g docosahexaenoic acid)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Corn oil (3 g linoleic acid)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fish oil and Corn oil
Number of subjects: 32
Study: 337220

Group type: EXPERIMENTAL
Intervention: Hypnotic analgesia procedure
Number of subjects: 0
Study: 30389377

Group type: EXPERIMENTAL
Intervention: Behavioral nutrition intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study: 29083219

Group type: EXPERIMENTAL
Intervention: Enhanced-PAM (6 MI calls including SHSe feedback)
Number of subjects: 339

Group type: COMPARATOR
Intervention: PAM (6 contact control calls)
Number of subjects: 339
Study: 25733632

Group type: EXPERIMENTAL
Intervention: High-glycemic index (HGI) meal (GI92)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-glycemic index (LGI) meal (GI37)
Number of subjects: 10
Study: 23135605

Group type: EXPERIMENTAL
Intervention: Salvinorin A (0.375-21 μg/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Salvinorin A
Number of subjects: 8
Study: 21751253

Group type: EXPERIMENTAL
Intervention: Multi-vitamin/mineral
Number of subjects: 198
Study: 19821969

Group type: EXPERIMENTAL
Intervention: Adiponectin levels
Number of subjects: 137
Study: 16464327

Group type: EXPERIMENTAL
Intervention: Patients recruited by GPs
Number of subjects: 166

Group type: COMPARATOR
Intervention: Patients recruited by advertisement
Number of subjects: 166
Study: 15238454

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 120
Study: 11743506

Group type: EXPERIMENTAL
Intervention: Dornase alfa 2.5 mg once daily
Number of subjects: 474

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study: 9565416

Group type: EXPERIMENTAL
Intervention: L-thyroxine (8 microg/kg birth weight per day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 8168332

Group type: EXPERIMENTAL
Intervention: Intravenous ouabain
Number of subjects: 0
Study: 2908528

Group type: EXPERIMENTAL
Intervention: KC8702 (new method vaccine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 21A (conventional vaccine)
Number of subjects: 0
Study: 31186619

Group type: EXPERIMENTAL
Intervention: 2800 ppm dentifrice
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5000 ppm dentifrice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional dentifrice
Number of subjects: 60
Study: 29231610

Group type: EXPERIMENTAL
Intervention: Fire needling therapy applied after ovulation and at the end of the premenstrual stage.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Regular sequential therapy of acupuncture (control group).
Number of subjects: 68
Study: 25262192

Group type: EXPERIMENTAL
Intervention: Oral gabapentin
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Oral gabapentin and intradermal injection of lidocaine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 23008027

Group type: EXPERIMENTAL
Intervention: Acridine orange therapy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Conventional wide-margin resection
Number of subjects: 170
Study: 21684389

Group type: EXPERIMENTAL
Intervention: Audiocomputer-delivered tailored feedback intervention
Number of subjects: 566

Group type: COMPARATOR
Intervention: No intervention (identical assessment without feedback)
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Increase in self-perceived HIV risk (for women)
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Increase in self-perceived HIV risk (for men)
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Reported HIV risk
Number of subjects: 566
Study: 18377149

Group type: EXPERIMENTAL
Intervention: Spousal confidence in care‐recipient recovery
Number of subjects: 109

Group type: COMPARATOR
Intervention: Functional Limitations Profile
Number of subjects: 109
Study: 17138198

Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system (40 mug fentanyl, 10-minute infusion/lockout, up to 6 doses/h)
Number of subjects: 799

Group type: COMPARATOR
Intervention: Morphine intravenous patient-controlled analgesia (1-mg morphine bolus, 5-minute lockout, up to 10 mg/h)
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system
Number of subjects: 799

Group type: COMPARATOR
Intervention: Morphine intravenous patient-controlled analgesia
Number of subjects: 799
Study: 12775315

Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 983

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 983
Study: 10703677

Group type: EXPERIMENTAL
Intervention: Intravenous iron dextran (ivID) protocol, 100 mg loading doses for 2 weeks followed by 25 to 150 mg weekly for 6 months, targeting TSAT between 30 and 50%.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group receiving ivID doses of 25 to 150 mg/week for 6 months, targeting TSAT of 20 to 30%.
Number of subjects: 42
Study: 9200247

Group type: EXPERIMENTAL
Intervention: Imagery and verbal labeling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagery alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demonstrated movement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guided movement
Number of subjects: 0

Group type: COMPARATOR
Intervention: No rehearsal strategy (control condition)
Number of subjects: 0
Study: 1546065

Group type: EXPERIMENTAL
Intervention: BN 52021 pretreatment in FU group
Number of subjects: 12

Group type: COMPARATOR
Intervention: No intervention in RU group
Number of subjects: 12
Study: 3890032

Group type: EXPERIMENTAL
Intervention: Systematic extensive surgery or radiotherapy on the initial tumor volume
Number of subjects: 81

Group type: COMPARATOR
Intervention: Combined chemotherapy using vincristine, dactinomycin, adriamycin, cyclophosphamide until maximum tumor reduction, followed by radiotherapy or surgery on the residual mass only
Number of subjects: 81
Study: 31107579

Group type: EXPERIMENTAL
Intervention: Functional dyspepsia
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Post-prandial distress syndrome
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Eosinophilia in the second part of duodenum
Number of subjects: 213
Study: 29886815

Group type: EXPERIMENTAL
Intervention: High-Intensity Jump-Based Aquatic Exercise (HIIAE) program, 24 weeks, 30 minutes per session
Number of subjects: 25
Study: 27906653

Group type: EXPERIMENTAL
Intervention: Longer left ventricular electric delay (QLV)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Longer QLV (≥median)
Number of subjects: 426
Study: 24296814

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (AtDCS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo transcranial direct current stimulation (PtDCS)
Number of subjects: 16
Study: 22417382

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchangers (HMEs)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Heated humidifiers (HH)
Number of subjects: 81
Study: 20700733

Group type: EXPERIMENTAL
Intervention: Writing of numbers (small vs large)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Writing of letters
Number of subjects: 0
Study: 18402095

Group type: EXPERIMENTAL
Intervention: Primer and bond (3M Scotch Bond)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No primer and bond
Number of subjects: 78
Study: 16521640

Group type: EXPERIMENTAL
Intervention: Sickle cell anemia patients
Number of subjects: 25
Study: 12450951

Group type: EXPERIMENTAL
Intervention: Stable-good premorbid functioning group
Number of subjects: 535

Group type: COMPARATOR
Intervention: Stable-poor premorbid functioning group
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Cognitive measures
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Positive syndrome subscale of the Positive and Negative Syndrome Scale
Number of subjects: 535
Study: 11515806

Group type: EXPERIMENTAL
Intervention: Cervical spinal manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study: 9140153

Group type: EXPERIMENTAL
Intervention: Omeprazole (80 mg as bolus, followed by 8 mg/h for 72 hours, plus 20 mg orally from day 3 until follow-up on day 21)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 8430920

Group type: EXPERIMENTAL
Intervention: Cetirizine 40 mg
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 3327892

Group type: EXPERIMENTAL
Intervention: Nicergoline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29268153

Group type: EXPERIMENTAL
Intervention: Symptoms of depression assessed using the Patient Health Questionnaire (PHQ)
Number of subjects: 11246

Group type: EXPERIMENTAL
Intervention: Symptoms of generalized anxiety assessed using the Patient Health Questionnaire (PHQ)
Number of subjects: 11246

Group type: EXPERIMENTAL
Intervention: Combined symptoms of depression and generalized anxiety
Number of subjects: 11246

Group type: EXPERIMENTAL
Intervention: Co-morbidity with symptoms of generalized anxiety
Number of subjects: 11246

Group type: EXPERIMENTAL
Intervention: Co-morbidity with somatic symptoms, alcohol use problems, and disability
Number of subjects: 11246

Group type: EXPERIMENTAL
Intervention: Sociodemographic factors associated with symptoms of depression or generalized anxiety
Number of subjects: 11246
Study: 28923118

Group type: EXPERIMENTAL
Intervention: Whole-body cooling with usual care
Number of subjects: 408

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 408
Study: 24589123

Group type: EXPERIMENTAL
Intervention: Cognitive Control Training (CCT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Peripheral Vision Training (PVT)
Number of subjects: 48
Study: 23288914

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 21891871

Group type: EXPERIMENTAL
Intervention: Galantamine treatment
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Discontinued galantamine treatment
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo (control group from previous trials)
Number of subjects: 258
Study: 17932613

Group type: EXPERIMENTAL
Intervention: Active treatment (trans-sacral magnetic stimulation)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (sham device)
Number of subjects: 63
Study: 16626573

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mesenchymal stem cells (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline (control, n = 12)
Number of subjects: 24
Study: 15107912

Group type: EXPERIMENTAL
Intervention: Paradontax dentifrice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard dentifrice with fluoride (Control)
Number of subjects: 30
Study: 10618026

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Second mood stabilizer (lithium carbonate or divalproex sodium)
Number of subjects: 27
Study: 9169961

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 8247887

Group type: EXPERIMENTAL
Intervention: Experimental approach to preparation for surgery; details on dosage and duration not available.
Number of subjects: 0
Study: 31461220

Group type: EXPERIMENTAL
Intervention: Intermediate endpoint associated with survival in a randomized phase 2 trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Futility interim analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cure proportion model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized phase 2 trial
Number of subjects: 0
Study: 30129666

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 200 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10
Study: 27510630

Group type: EXPERIMENTAL
Intervention: T1w‐3D black‐blood turbo spin echo (TSE) sequence with variable flip angles
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 70
Study: 25786056

Group type: EXPERIMENTAL
Intervention: Twin-block appliance (TB)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Forsus Fatigue Resistant Device (FRD)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (untreated Class II malocclusion)
Number of subjects: 28
Study: 23527347

Group type: EXPERIMENTAL
Intervention: Silicone prostheses
Number of subjects: 42

Group type: COMPARATOR
Intervention: CPE prostheses
Number of subjects: 42
Study: 21051130

Group type: EXPERIMENTAL
Intervention: Mobile AED Map
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 18374840

Group type: EXPERIMENTAL
Intervention: Insulin glargine (once daily)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Insulin lispro (thrice daily)
Number of subjects: 418
Study: 17017665

Group type: EXPERIMENTAL
Intervention: Intravenous itraconazole
Number of subjects: 96

Group type: COMPARATOR
Intervention: Amphotericin B deoxycholate
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 96
Study: 14571829

Group type: EXPERIMENTAL
Intervention: OCM-O group (omeprazole 20 mg once daily)
Number of subjects: 79

Group type: COMPARATOR
Intervention: OCM group (without acid suppressing agents)
Number of subjects: 79
Study: 10774106

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous administration of 1 g of Dipyrone
Number of subjects: 50
Study: 8918414

Group type: COMPARATOR
Intervention: Placebo antiemetic
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Granisetron, Metoclopramide, Ondansetron
Number of subjects: 48
Study: 1432803

Group type: EXPERIMENTAL
Intervention: Cingulum bar (test) removable partial denture framework
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linguoplate (control) removable partial denture framework
Number of subjects: 0
Study: 2866338

Group type: EXPERIMENTAL
Intervention: Stilboestrol 5 mg daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29628406

Group type: EXPERIMENTAL
Intervention: Eccentric training (ECC)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Eccentric training combined to NMES (ECC+NMES)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 27182761

Group type: EXPERIMENTAL
Intervention: Modified Shuttle Test (MST)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cardiopulmonary Exercise Test (CPET)
Number of subjects: 20
Study: 24534170

Group type: EXPERIMENTAL
Intervention: gelled pectin (10 g)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: viscous pectin (10 g)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: gelled test product
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: capsules
Number of subjects: 29
Study: 22417085

Group type: EXPERIMENTAL
Intervention: Reduced individualized GH dose (RID, n=28)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Unchanged individualized GH dose (UID, n=37)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard GH dose (FIX, n=33)
Number of subjects: 98
Study: 19685066

Group type: EXPERIMENTAL
Intervention: Transcervical amnioinfusion
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control (no amnioinfusion)
Number of subjects: 292
Study: 16394962

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral feedback intervention
Number of subjects: 79

Group type: COMPARATOR
Intervention: Information-only condition
Number of subjects: 79
Study: 15315244

Group type: EXPERIMENTAL
Intervention: Optimal seated positioning in individually fitted furniture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Suboptimal seated positioning in standard classroom furniture
Number of subjects: 40
Study: 11513785

Group type: EXPERIMENTAL
Intervention: Strategic Management Simulation (SMS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation performance measures (activity level, response speed, initiative, adequate usage of and appropriate search for relevant information)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Faculty ratings
Number of subjects: 0
Study: 9266623

Group type: EXPERIMENTAL
Intervention: r‐HuEPO (300 U/kg body weight)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combination therapy (oral iron + r‐HuEPO)
Number of subjects: 46

Group type: COMPARATOR
Intervention: r‐HuEPO alone
Number of subjects: 46
Study: 8278067

Group type: EXPERIMENTAL
Intervention: Meclofenamic acid 100 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketoprofene 50 mg
Number of subjects: 60
Study: 2874415

Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 20

Group type: COMPARATOR
Intervention: lactose
Number of subjects: 20
Study: 30601709

Group type: EXPERIMENTAL
Intervention: CJR program (bundled payments)
Number of subjects: 803
Study: 27845950

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 64
Study: 26654962

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 24126369

Group type: EXPERIMENTAL
Intervention: Transarterial ethanol ablation (TEA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 200
Study: 23029408

Group type: EXPERIMENTAL
Intervention: 7vPnC followed by PPV
Number of subjects: 80

Group type: COMPARATOR
Intervention: PPV
Number of subjects: 80
Study: 19031485

Group type: EXPERIMENTAL
Intervention: Negative peer evaluation outcome
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Positive peer evaluation outcome
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Neutral peer evaluation outcome
Number of subjects: 142
Study: 17762286

Group type: EXPERIMENTAL
Intervention: Autologous Conditioned Serum (ACS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: 5 mg triamcinolone
Number of subjects: 84

Group type: COMPARATOR
Intervention: 10 mg triamcinolone
Number of subjects: 84
Study: 15747895

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention (EG-IA) - tooth brushing taught and monitored by an occupational therapist
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo activity (CG-IA) - weekly manicure by the same person
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention (EG)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo activity (CG)
Number of subjects: 61
Study: 11865274

Group type: EXPERIMENTAL
Intervention: Soy formula
Number of subjects: 170

Group type: COMPARATOR
Intervention: Extensively hydrolyzed formula
Number of subjects: 170
Study: 10461254

Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 19
Study: 8786245

Group type: EXPERIMENTAL
Intervention: rHu GM‐CSF
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2079571

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 3 million units thrice weekly for 14-16 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b therapy
Number of subjects: 50
Study: 37874

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of beta-blockers and diuretics
Number of subjects: 0